NCARDIA

In News

New platform to accelerate cardiac drug development - Leids Universitair Medisch Centrum | LUMC

Leids Universitair Medisch Centrum | LUMC - Jan 22, 2026

iPSC technology company Ncardia receives US$60 million investment - RegMedNet

RegMedNet - Nov 17, 2021

An ethical shift in NHP research: iPSC-derived cardiomyocytes for safer pharmacology - Drug Target Review

Drug Target Review - Oct 06, 2025

Ncardia Launches Cellistic™, the Only iPSC-based Cell Therapy Process Development & Manufacturing Partner Purpose-built to Make Large-scale Allogeneic Cell Therapy Production a Reality Today - bioinformant.com

bioinformant.com - Apr 26, 2022

Ncardia Launches Ncyte® Heart in a Box to Advance Cardiovascular Research and Precision Medicine - Business Wire

Business Wire - Jan 27, 2025

iPSC-derived microglia may help advance ALS research, therapies - ALS News Today

ALS News Today - Jan 30, 2025

New panel of cell-based tests may help screen potential treatments - Parkinson's News Today

Parkinson's News Today - Sep 13, 2024

The Future of Allogeneic Cell Therapy is Off-the-Shelf and iPSC-Based – An Interview with Cellistic’s Founder and CTO, Stefan Braam, PhD - bioinformant.com

bioinformant.com - Oct 23, 2025

Ncardia Launches iPSC-Based Phenotypic Screening Service to Bring Human Disease Biology Earlier into Drug Discovery and Development - WTXL ABC 27

WTXL ABC 27 - Feb 04, 2019

Ncardia and BlueRock Therapeutics Announce Collaboration Agreement and Licensing of Process Development Technologies for the Manufacture of iPSC-derived Cardiomyocytes - Business Wire

Business Wire - Jan 21, 2020

€ 50 mln en strategisch partnership voor wereldleidend Ncardia uit Leiden - InnovationQuarter

InnovationQuarter - Nov 16, 2021

NCardia, a Global Force in hiPSC Drug Discovery and Development Products and Solutions - bioinformant.com

bioinformant.com - Sep 18, 2017

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment